AboutTim Remus, PhD

As director of the cancer service line team, Tim leads the development and delivery of Sg2’s cancer intelligence and is the expert advisor for all oncology-related consulting projects. His team is responsible for developing the publications, webinars, web postings, analytic deliverables and strategic insights that provide clients with an understanding of key trends as they prepare for the changing cancer care environment. Tim also works with the technology and innovation team tracking advancements in current/innovative medical and imaging devices and assisting health care executives make decisions around technology acquisition and adoption.

Tim helps organize Sg2’s annual AMC Summit conference and is a frequent speaker at client education and leadership sessions, and other Sg2 events. He has also presented on health care trends at local and national conferences.

Prior to joining Sg2, Tim managed publication strategy for pharmaceutical and medical device companies and published the results from ongoing and completed clinical trials. He also led speaker training events and developed materials designed to educate physicians on new drug therapies and disease states. Tim has extensive experience working in the fields of oncology, depression, hemostasis and diabetes.

Tim earned a PhD in molecular and cellular biochemistry from Loyola University Chicago. His work was published in scientific journals and presented at local, national and international scientific conferences. He graduated from Marquette University with
a BS in biochemistry.

"Analytics and expertise to help you understand market dynamics and capitalize opportunities for growth."

As of February 11, 2016, Vizient, Inc. has completed its purchase of MedAssets Sg2 and spend and clinical resource management segments from Pamplona Capital Management, LLC. MedAssets revenue cycle business will continue to operate as a wholly-owned subsidiary of Pamplona Capital Management LLP.

Follow Sg2 on Twitter Connect with Sg2 on LinkedIn Watch Sg2 on YouTube